Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

CUSIP: 45790W108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,967,756
Total 13F shares
52,395,972
Share change
-2,735,978
Total reported value
$145,138,301
Put/Call ratio
196%
Price per share
$2.77
Number of holders
103
Value change
-$16,307,259
Number of buys
60
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 45790W108?
CUSIP 45790W108 identifies INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) as of Q4 2024

As of 31 Dec 2024, Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,395,972 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Pivotal bioVenture Partners Investment Advisor LLC, Sofinnova Investments, Inc., Affinity Asset Advisors, LLC, Rock Springs Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, NEA Management Company, LLC, EVENTIDE ASSET MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 103 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.